Siyu Li

Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels

L. Qin, Zhaoyang Tang, Peng Li, 2022, Molecular therapy oncolytics.

GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD‑L1 expression via STAT1 signaling

Bin Liu, L. Qin, Xu-dong Hu, 2023, Oncology reports.

CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer

Ming Li, L. Qin, Zhaoyang Tang, 2022, Clinical and Experimental Medicine.